Contact Us   |   Sign In   |   Join
Menu

DEA announces rescheduling of all hydrocodone combination products (hcps)!

The DEA has announced that it is rescheduling all hydrocodone combination products (HCPs) from federal Schedule III to federal Schedule II effective October 6.  This change will impact how hydrocodone combination products are prescribed and dispensed in California.  Federal requirements for prescribing and dispensing Schedule II controlled substances will apply to all hydrocodone combination products.  This means, among other things, a very limited ability to orally prescribe HCPs and to authorize refills.

 

Click here for more information.

Sign In


Forgot your password?

Create Account

Career Opportunities
Featured Jobs
Upcoming CME Events more

2/4/2015 » 2/8/2015
54th Annual Convention

2015 H Street, Sacramento, CA 95811

(916) 822-5246

(916) 822-5247

opsc@opsc.org

Membership Software Powered by YourMembership.com®  ::  Legal/Privacy